Back to NewsPublished: 16 Jan 2026Download AppJoin TelegramCipla Shares Slip 3.5% as Lanreotide Supply Pause Raises Earnings Concerns#Cipla#pharma stocks#earnings risk#stock marketDownload AppJoin CommunityShare Article